Unfortunately, as the Government Accountability Office reports, the current National Biodefense Strategy does not assess non-Federal biodefense capabilities nor does it establish a mechanism for better coordination with non-Federal entities.
Hassan highlights gaps in the National Biodefense Strategy regarding non-Federal coordination.
Share
More from Maggie Hassan
I am pleased to see these important measures advance with strong bipartisan support, and I will continue working to bring down prescription drug costs for families across New Hampshire and the country.
For too long, Big Pharma has been abusing the patent process to block generic competition and keep drug prices for patients artificially high.
Drug smuggling through ports of entry at the Southern border remains the primary mode by which fentanyl enters the United States.
Other voices in this conversation
